Cargando…

Regulation of PGC-1α mediated by acetylation and phosphorylation in MPP+ induced cell model of Parkinson’s disease

Background: Parkinson’s disease (PD) is one of the most common neurodegenerative diseases with complex etiology in sporadic cases. Accumulating evidence suggests that oxidative stress and defects in mitochondrial dynamics are associated with the pathogenesis of PD. The oxidative stress and mitochond...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Fei, Li, Songlin, Wen, Zhipeng, Ye, Qiaoyue, Chen, Xiaochun, Ye, Qinyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288924/
https://www.ncbi.nlm.nih.gov/pubmed/32452827
http://dx.doi.org/10.18632/aging.103219
_version_ 1783545366605463552
author Fan, Fei
Li, Songlin
Wen, Zhipeng
Ye, Qiaoyue
Chen, Xiaochun
Ye, Qinyong
author_facet Fan, Fei
Li, Songlin
Wen, Zhipeng
Ye, Qiaoyue
Chen, Xiaochun
Ye, Qinyong
author_sort Fan, Fei
collection PubMed
description Background: Parkinson’s disease (PD) is one of the most common neurodegenerative diseases with complex etiology in sporadic cases. Accumulating evidence suggests that oxidative stress and defects in mitochondrial dynamics are associated with the pathogenesis of PD. The oxidative stress and mitochondrial dynamics are regulated strictly by peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α). We investigated whether acetylation and phosphorylation of PGC-1α contribute to protecting neuronal cell against oxidative stress. Results: We found that acetylation and phosphorylation mediated the nuclear translocation of PGC-1α protects against oxidative damage. In contrast to the increased nuclear PGC-1α, the cytosolic PGC-1α was decreased upon inhibition of GCN5 acetyltransferase. Similarly to the inhibition of GCN5 acetyltransferase, the increased nuclear PGC-1α and the decreased cytosolic PGC-1α were observed upon p38MAPK and AMPK activation. Briefly, the significantly increased nuclear PGC-1α is regulated either by inhibiting the acetylation of PGC-1α or by the phosphorylating PGC-1α, which results in a reduction in ROS. Conclusion: PGC-1α protects neuronal cells against MPP(+)-induced toxicity partially through the acetylation of PGC-1α mediated by GCN5, and mostly through the phosphorylation PGC-1α mediated by p38MAPK or AMPK. Therapeutic reagents activating PGC-1α may be valuable for preventing mitochondrial dysfunction in PD by against oxidative damage. Methods: With established the 1-methyl-4-phenylpyridinium (MPP(+))-induced cell model of PD, the effects of MPP(+) and experimental reagents on the cell viability was investigated. The expression of PGC-1α, general control of nucleotide synthesis 5 (GCN5), p38 mitogen-activated protein kinase (p38MAPK) and adenosine monophosphate activated protein kinase (AMPK) were detected by Western blotting and quantitative real-time PCR. The level of reactive oxygen species (ROS) was measured by flow cytometry. All statistical analyses were carried out using one-way ANOVA.
format Online
Article
Text
id pubmed-7288924
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-72889242020-06-22 Regulation of PGC-1α mediated by acetylation and phosphorylation in MPP+ induced cell model of Parkinson’s disease Fan, Fei Li, Songlin Wen, Zhipeng Ye, Qiaoyue Chen, Xiaochun Ye, Qinyong Aging (Albany NY) Research Paper Background: Parkinson’s disease (PD) is one of the most common neurodegenerative diseases with complex etiology in sporadic cases. Accumulating evidence suggests that oxidative stress and defects in mitochondrial dynamics are associated with the pathogenesis of PD. The oxidative stress and mitochondrial dynamics are regulated strictly by peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α). We investigated whether acetylation and phosphorylation of PGC-1α contribute to protecting neuronal cell against oxidative stress. Results: We found that acetylation and phosphorylation mediated the nuclear translocation of PGC-1α protects against oxidative damage. In contrast to the increased nuclear PGC-1α, the cytosolic PGC-1α was decreased upon inhibition of GCN5 acetyltransferase. Similarly to the inhibition of GCN5 acetyltransferase, the increased nuclear PGC-1α and the decreased cytosolic PGC-1α were observed upon p38MAPK and AMPK activation. Briefly, the significantly increased nuclear PGC-1α is regulated either by inhibiting the acetylation of PGC-1α or by the phosphorylating PGC-1α, which results in a reduction in ROS. Conclusion: PGC-1α protects neuronal cells against MPP(+)-induced toxicity partially through the acetylation of PGC-1α mediated by GCN5, and mostly through the phosphorylation PGC-1α mediated by p38MAPK or AMPK. Therapeutic reagents activating PGC-1α may be valuable for preventing mitochondrial dysfunction in PD by against oxidative damage. Methods: With established the 1-methyl-4-phenylpyridinium (MPP(+))-induced cell model of PD, the effects of MPP(+) and experimental reagents on the cell viability was investigated. The expression of PGC-1α, general control of nucleotide synthesis 5 (GCN5), p38 mitogen-activated protein kinase (p38MAPK) and adenosine monophosphate activated protein kinase (AMPK) were detected by Western blotting and quantitative real-time PCR. The level of reactive oxygen species (ROS) was measured by flow cytometry. All statistical analyses were carried out using one-way ANOVA. Impact Journals 2020-05-26 /pmc/articles/PMC7288924/ /pubmed/32452827 http://dx.doi.org/10.18632/aging.103219 Text en Copyright © 2020 Fan et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Fan, Fei
Li, Songlin
Wen, Zhipeng
Ye, Qiaoyue
Chen, Xiaochun
Ye, Qinyong
Regulation of PGC-1α mediated by acetylation and phosphorylation in MPP+ induced cell model of Parkinson’s disease
title Regulation of PGC-1α mediated by acetylation and phosphorylation in MPP+ induced cell model of Parkinson’s disease
title_full Regulation of PGC-1α mediated by acetylation and phosphorylation in MPP+ induced cell model of Parkinson’s disease
title_fullStr Regulation of PGC-1α mediated by acetylation and phosphorylation in MPP+ induced cell model of Parkinson’s disease
title_full_unstemmed Regulation of PGC-1α mediated by acetylation and phosphorylation in MPP+ induced cell model of Parkinson’s disease
title_short Regulation of PGC-1α mediated by acetylation and phosphorylation in MPP+ induced cell model of Parkinson’s disease
title_sort regulation of pgc-1α mediated by acetylation and phosphorylation in mpp+ induced cell model of parkinson’s disease
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288924/
https://www.ncbi.nlm.nih.gov/pubmed/32452827
http://dx.doi.org/10.18632/aging.103219
work_keys_str_mv AT fanfei regulationofpgc1amediatedbyacetylationandphosphorylationinmppinducedcellmodelofparkinsonsdisease
AT lisonglin regulationofpgc1amediatedbyacetylationandphosphorylationinmppinducedcellmodelofparkinsonsdisease
AT wenzhipeng regulationofpgc1amediatedbyacetylationandphosphorylationinmppinducedcellmodelofparkinsonsdisease
AT yeqiaoyue regulationofpgc1amediatedbyacetylationandphosphorylationinmppinducedcellmodelofparkinsonsdisease
AT chenxiaochun regulationofpgc1amediatedbyacetylationandphosphorylationinmppinducedcellmodelofparkinsonsdisease
AT yeqinyong regulationofpgc1amediatedbyacetylationandphosphorylationinmppinducedcellmodelofparkinsonsdisease